8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Jul 24, 2019)

Filed July 24, 2019For Securities:ELV

Summary

This 8-K filing by Elevance Health, Inc. (then Anthem, Inc.) on July 24, 2019, primarily serves to furnish the company's second-quarter 2019 financial results, as detailed in a press release (Exhibit 99.1). While the 8-K itself doesn't contain the specific financial figures, it signals the release of this important operational data to the public and the market. Investors should refer to the furnished press release for details on revenue, earnings, membership, and any updated guidance for the remainder of 2019. The filing also includes a standard 'Forward-Looking Statements' section, outlining the inherent risks and uncertainties associated with the company's future projections, which is crucial for investors to consider when evaluating the company's outlook.

Key Highlights

  • 1Anthem, Inc. (now Elevance Health) announced its second-quarter 2019 financial results on July 24, 2019.
  • 2The primary purpose of this 8-K is to officially furnish the press release containing these Q2 2019 financial results.
  • 3Investors are directed to Exhibit 99.1, the press release dated July 24, 2019, for the detailed financial performance.
  • 4The filing includes standard cautionary statements regarding forward-looking statements, highlighting potential risks and uncertainties.
  • 5Key risk factors mentioned include regulatory changes (ACA), healthcare cost trends, provider contracting, premium rate approvals, competitive pressures, and litigation outcomes.
  • 6The company is not an 'emerging growth company' and has not elected to use extended transition periods for new accounting standards.
  • 7The information furnished in this report is not considered 'filed' for Section 18 purposes, meaning it does not carry the same legal implications as formally filed data.

Frequently Asked Questions